Pharyngeal Gonorrhea – Evidence‑Based Screening, Diagnosis, and Follow‑Up

Epidemiology and Transmission Reservoir

The pharynx serves as a major silent reservoir for Neisseria gonorrhoeae transmission and the development of antimicrobial resistance; because >90 % of infections are asymptomatic, reliance on patient‑reported throat symptoms is insufficient and systematic screening based on sexual history is required. 1

NAAT is the primary diagnostic method for pharyngeal specimens, but every positive NAAT result must be confirmed with an additional test to avoid false‑positives caused by cross‑reactivity with commensal Neisseria species (e.g., N. meningitidis, N. sicca, N. lactamica, N. cinerea). 2

Culture remains essential for performing antimicrobial susceptibility testing when treatment failure is suspected, despite its low recovery rate from pharyngeal sites. 3
All presumptive isolates obtained from culture must be definitively identified by at least two distinct methods (biochemical, enzyme‑substrate, or serologic) to ensure accurate species determination. 2

Use of saliva as a sexual lubricant is identified as a behavioral risk factor for acquiring pharyngeal gonorrhea. 1
Engaging in kissing with partners known to have gonorrhea increases the risk of pharyngeal infection. 1

A test‑of‑cure (TOC) is recommended 7–14 days after completing therapy for pharyngeal gonorrhea to verify eradication. 3
Pharyngeal infections are more difficult to eradicate than urogenital or anorectal infections, leading to lower cure rates. [4][5]
Few antimicrobial regimens achieve cure rates exceeding 90 % for pharyngeal gonorrhea, underscoring the need for careful regimen selection and follow‑up. [4][6]
Asymptomatic pharyngeal infections can persist for up to 16 weeks, providing a prolonged window for genetic exchange and the emergence of antimicrobial resistance. 1